156 related articles for article (PubMed ID: 10778927)
1. Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats.
Zuideveld KP; Treijtel N; Van der Graaf PH; Danhof M
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):67-73. PubMed ID: 10778927
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
Yu H; Lewander T
Eur Neuropsychopharmacol; 1997 Aug; 7(3):165-72. PubMed ID: 9213074
[TBL] [Abstract][Full Text] [Related]
3. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
Zuideveld KP; Treijtel N; Maas HJ; Gubbens-Stibbe JM; Peletier LA; van Der Graaf PH; Danhof M
J Pharmacol Exp Ther; 2002 Jan; 300(1):330-8. PubMed ID: 11752133
[TBL] [Abstract][Full Text] [Related]
4. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
5. Oral cavity absorption of (R)-8-hydroxy-2-(di-n-propylamino)tetralin and (S)-8-acetyl-2-(di-n-propylamino)tetralin in the rat.
Yu H; Liu Y; Hacksell U; Lewander T
J Pharm Pharmacol; 1996 Jan; 48(1):41-5. PubMed ID: 8722493
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability after intramuscular injection of the 5-HT
Pfitzer S; Woodward AP; Laubscher L; Warren K; Vaughan-Higgins R; Raath JP; Laurence M
J Vet Pharmacol Ther; 2019 May; 42(3):251-257. PubMed ID: 30656714
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of (R)-, (R, S)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on hippocampal serotonin release and induction of hypothermia in awake rats.
Yoshitake T; Kehr J
Life Sci; 2004 Apr; 74(23):2865-75. PubMed ID: 15050424
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
Casanovas JM; Vilaró MT; Mengod G; Artigas F
J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
[TBL] [Abstract][Full Text] [Related]
9. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
10. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
11. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
12. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
Clarke RW; Ogilvie J; Houghton AK
Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic and pharmacokinetic studies in rats of S-8-(2-Furyl)- and R-8-phenyl-2-(di-n-propylamino) tetralin, two novel 5-HT1A receptor agonists in-vitro with different properties in-vivo.
Yu H; Liu Y; Li HB; Martin AR; Hacksell U; Lewander T
J Pharm Pharmacol; 1997 Feb; 49(2):169-77. PubMed ID: 9055190
[TBL] [Abstract][Full Text] [Related]
14. The ontogeny of tolerance to the 5-HT1A agonist 8-OH-DPAT: a study in the rat.
Johansson-Wallsten CE; Meyerson BJ
Neuropharmacology; 1994; 33(3-4):325-30. PubMed ID: 7984269
[TBL] [Abstract][Full Text] [Related]
15. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
Yu H; Liu Y; Hacksell U; Lewander T
Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
[TBL] [Abstract][Full Text] [Related]
16. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of (R)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on the monosynaptic spinal reflex in rats.
Honda M; Ono H
Eur J Pharmacol; 1999 Jun; 373(2-3):171-9. PubMed ID: 10414436
[TBL] [Abstract][Full Text] [Related]
18. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
Eltayb A; Lindblom S; Oerther S; Ahlenius S
Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
Sugimoto Y; Kimura I; Watanabe Y; Yamada J
Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
